Arbaclofen Extended-Release Reduces Multiple Sclerosis-Related Spasticity
Arbaclofen extended-release tablets twice-daily are safe and effective for the treatment of spasticity in multiple sclerosis.
United States Multiple Sclerosis Centers Neurology Advisor Total Numeric Transformed Modified Ashworth Scale Most Affected Limb Clinical Global Impress
Source: neurologyadvisor.com